Related Experiment Video
Updated: Jul 14, 2026

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
Published on: April 25, 2025
[Functional renal investigation in Fabry disease]
Marc Froissart1, Karelle Benistan, Dominique P Germain
1Département de Physiologie, Hôpital Européen Georges-Pompidou, Assistance Publique-Hôpitaux de Paris, INSERM U872 et Université Paris Descartes, Paris (75), France. marc.froissart@egp.aphp.fr
Enzyme Replacement Therapy (ERT) helps clear Fabry disease deposits, but its effect on slowing kidney function decline needs more study, especially in advanced chronic kidney disease (CKD). Careful GFR estimation is crucial for monitoring Fabry disease progression.
Area of Science:
- Nephrology
- Genetics
- Biochemistry
Context:
- Fabry disease is a genetic disorder causing progressive kidney function decline.
- Proteinuria is an early indicator of kidney involvement in Fabry disease.
- Current recommendations for renoprotection in chronic kidney disease (CKD) include Enzyme Replacement Therapy (ERT) and anti-proteinuric treatments.
Purpose:
- To evaluate the efficacy of ERT in clearing globotriaosylceramide deposits.
- To assess the functional protective effect of ERT on Glomerular Filtration Rate (GFR) decline in Fabry patients, particularly those with advanced CKD (stage 3 or higher).
- To emphasize the importance of accurate GFR estimation in managing CKD in Fabry disease.
Summary:
- ERT effectively clears globotriaosylceramide deposits in early Fabry disease.
- The renoprotective impact of ERT on GFR decline requires further validation, especially in later stages of CKD.
- Creatinine-based GFR estimation formulas may be unreliable in Fabry patients; direct GFR measurement is recommended for accurate progression characterization.
Impact:
- Highlights the need for comprehensive renoprotective strategies in Fabry disease.
- Underscores the importance of validated GFR measurement for clinical decision-making.
- Informs therapeutic approaches for managing kidney disease in Fabry patients.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Imaging Studies VII: Vascular Imaging
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Serum Studies: Renal Function Tests
